AGN-242428 in the Treatment of Plaque Psoriasis
Public ClinicalTrials.gov record NCT03339999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AGN-242428 in Patients With Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of 3 doses of AGN-242428 in adult participants with moderate to severe plaque-type psoriasis.
Study identification
- NCT ID
- NCT03339999
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 15, 2017 (Actual)
- Primary completion
- Mar 22, 2018 (Actual)
- Completion
- Apr 20, 2018 (Actual)
- Last update posted
- Apr 6, 2021
2017 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| Radiant Tucson | Tucson | Arizona | 85712 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| University Clinical Trials | San Diego | California | 92123 | — |
| Horizons Clinical Research Center | Denver | Colorado | 80220 | — |
| Belleair Research Center | Pinellas Park | Florida | 33781 | — |
| Dawes Fretzin Dermatology Group | Indianapolis | Indiana | 46256 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| South Bend Clinic | South Bend | Indiana | 46617 | — |
| Kansas City Dermatology | Overland Park | Kansas | 66215 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Arlington Research Center, Inc | Arlington | Texas | 76011 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03339999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03339999 live on ClinicalTrials.gov.